AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 181 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $410,000 | -23.1% | 8,605 | -47.8% | 0.05% | -29.4% |
| Q3 2019 | $533,000 | -88.7% | 16,474 | -82.6% | 0.07% | -79.2% |
| Q2 2019 | $4,713,000 | -17.2% | 94,500 | +12.0% | 0.33% | +24.3% |
| Q1 2019 | $5,691,000 | -9.0% | 84,400 | -37.8% | 0.26% | -39.0% |
| Q4 2018 | $6,252,000 | -22.3% | 135,600 | +30.0% | 0.43% | -6.5% |
| Q3 2018 | $8,043,000 | +864.4% | 104,300 | +614.4% | 0.46% | +924.4% |
| Q4 2017 | $834,000 | -74.6% | 14,600 | -70.3% | 0.04% | -74.4% |
| Q3 2017 | $3,284,000 | -24.6% | 49,200 | -41.9% | 0.18% | -34.6% |
| Q2 2017 | $4,357,000 | +111.4% | 84,700 | +139.9% | 0.27% | +106.9% |
| Q1 2017 | $2,061,000 | -1.2% | 35,300 | -29.4% | 0.13% | -24.4% |
| Q4 2016 | $2,086,000 | +45.6% | 50,000 | +59.7% | 0.17% | -19.2% |
| Q2 2014 | $1,433,000 | – | 31,300 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |